TEPADINA is indicated, in combination with other chemotherapy medicinal products: • with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; • when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.
Learn about the various treatments currently used and in trials for haematopoietic stem cell transplantation.
Thrombolytic microangiopathy and graft versus host disease are potentially life-threatening complications of haematopoietic stem cell transplantation.